Structured physical exercise improves neuropsychiatric symptoms in acute dementia care: a hospital-based RCT

Alzheimer’s Research & Therapy

Wiebren Zijlstra¹  Tim Fleiner¹  Peter Haussermann²  Marleen Gersie²  Hannah Dauth² 

[1] Institute of Movement and Sport Gerontology, German Sport University Cologne;LVR-Hospital Cologne, Department of Geriatric Psychiatry & Psychotherapy, Academic Teaching Hospital of the University of Cologne;

关键词: Dementia;    Hospital;    Neuropsychiatric signs and symptoms;    Exercise;    Physical activity;    Social stimulation;   

DOI  :  10.1186/s13195-017-0289-z

来源: DOAJ

【 摘 要 】

Abstract Background The primary objective of this trial is to investigate the effects of a short-term exercise program on neuropsychiatric signs and symptoms in acute hospital dementia care. Methods Within a hospital-based randomized controlled trial, the intervention group conducted a 2-week exercise program with four 20-min exercise sessions on 3 days per week. The control group conducted a social stimulation program. Effects on neuropsychiatric signs and symptoms were measured via the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change, the Neuropsychiatric Inventory, and the Cohen-Mansfield Agitation Inventory. The antipsychotic and sedative dosage was quantified by olanzapine and diazepam equivalents. Results Eighty-five patients were randomized via minimization to an intervention group (IG) and a control group (CG). Seventy patients (82%) (mean age 80 years, 33 females, mean Mini Mental State Examination score 18.3 points) completed the trial. As compared to the CG (n = 35), the IG (n = 35) showed significantly reduced neuropsychiatric signs and symptoms. Especially, agitated behavior and lability improved. There were no between-group differences concerning antipsychotic and benzodiazepine medication. Conclusions This exercise program is easily applicable in hospital dementia care and significantly reduces neuropsychiatric signs and symptoms in patients suffering from predominantly moderate stages of dementia. Trial registration German Clinical Trial Register DRKS00006740 . Registered 28 October 2014.

【 授权许可】

Unknown